Based on studies in other cancer cell types, specific pathways that may be involved in the observed effects of Lunasin on melanoma CICs include suppression of Akt, ERK1/2, and NF-κB and activation of the tumor suppressor PTEN [32, 33, 35, 60]. Here, MAPK3 is linked to cancer.